Dapagliflozin binds PRMT7 to inhibit p38 MAPK phosphorylation and macrophage foam cell formation in atherosclerosis. [PDF]
Fang Y +15 more
europepmc +1 more source
ADAMTS7 promotes smooth muscle foam cell expansion in atherosclerosis. [PDF]
Chung A +11 more
europepmc +1 more source
A hierarchical theranostic nanoagent for multimodal imaging and targeted foam cell intervention in atherosclerosis. [PDF]
Song J +6 more
europepmc +1 more source
Palmitic and oleic acids induce macrophage foam cell formation through C/EBPβ activation. [PDF]
Wang G +7 more
europepmc +1 more source
A foam cell-targeted lipophagy restoration strategy stabilizes vulnerable atherosclerotic plaques. [PDF]
Li H +11 more
europepmc +1 more source
S-nitrosylation of HINT1 in macrophages aggravates foam cell formation and atherosclerosis. [PDF]
Tang K +13 more
europepmc +1 more source
Narcissoside attenuates atherosclerosis by suppressing CD36-mediated foam cell formation via upregulation of NR4A1. [PDF]
Wang Z +9 more
europepmc +1 more source
ANPEP governs macrophage lipid metabolism and macrophage foam cell formation in large-artery atherosclerotic stroke. [PDF]
Bai F +9 more
europepmc +1 more source
Tafolecimab mitigates ox-LDL-induced macrophage foam cell formation and inflammation by modulating SR-A/ABCG1 expression and inhibiting the NF-κB/MAPK pathways. [PDF]
Yu X, Liu X, Dang Y, Liu R.
europepmc +1 more source
Tanshinone IIA inhibits foam cell formation and alleviates atherosclerosis by regulating the Hedgehog signaling pathway through TRPM2 suppression. [PDF]
Yin Y +12 more
europepmc +1 more source

